Biocon Biologics receives EIR from USFDA for two manufacturing facilities in Bengaluru

Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., said on Thursday it has received the Establishment Inspection Report (EIR) from the USFDA (the United States Food and Drug Administration) for the pre-approval inspection at two of its biologics manufacturing facilities in Bengaluru

Press Trust of India April 16, 2020 11:38:41 IST
Biocon Biologics receives EIR from USFDA for two manufacturing facilities in Bengaluru

Bengaluru: Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., said on Thursday it has received the Establishment Inspection Report (EIR) from the USFDA (the United States Food and Drug Administration) for the pre-approval inspection at two of its biologics manufacturing facilities in Bengaluru.

Biocon Biologics receives EIR from USFDA for two manufacturing facilities in Bengaluru

Biocon. Representational image. Reuters.

The inspection was conducted between 10 September and 19 September, 2019, a company spokesperson said, adding, Biocon Biologics has responded to the regulator on the eight observations from this inspection, in October last year.

Click here to follow LIVE news and updates on stock markets

Subsequently, Biocon Biologics has received approvals for the two products Trastuzumab (Drug Product) and Pegfilgrastim (Drug Substance) from the USFDA in 2019.

"The receipt of the EIR indicates a successful closure of the inspection," the spokesperson said. "The formal closure of the USFDA inspection is expected to enable filing of marketing authorisation applications for our biosimilar products in several global markets."

Updated Date:

also read

WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months
India

WHO rejects SII’s proposal seeking extension of Covishield’s shelf life from 6 to 9 months

The UN body has also sought a meeting with the Drugs Controller General of India to discuss the matter 10:12

Former Bigg Boss contestant Ajaz Khan arrested by NCB in connection to a drugs case
Entertainment

Former Bigg Boss contestant Ajaz Khan arrested by NCB in connection to a drugs case

Ajaz Khan was questioned by the NCB at its office in south Mumbai and his statement was recorded late Tuesday night.

From the COVID-19 pandemic, experts have a roadmap to lowering the costs of medicine
World

From the COVID-19 pandemic, experts have a roadmap to lowering the costs of medicine

The decades-long trend of rising drug prices, described by Eroom’s Law, is in part a result of regulatory inefficiencies.